RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Activity
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

205 hedge funds and large institutions have $2.58B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 47 increasing their positions, 65 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
205
Holders Change
+37
Holders Change %
+22.02%
% of All Funds
3.28%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.14%
New
63
Increased
47
Reduced
65
Closed
26
Calls
$222M
Puts
$110M
Net Calls
+$111M
Net Calls Change
+$121M

Top Buyers

1
PA
Perceptive Advisors
New York
$197M
2
DTC
Deep Track Capital
Connecticut
$66.3M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$33.1M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$31.6M
5
Invesco
Invesco
Georgia
$36.7M

Top Sellers

1
FAM
Fred Alger Management
New York
$15.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
$42.7M
3
Millennium Management
Millennium Management
New York
$19.5M
4
Morgan Stanley
Morgan Stanley
New York
$22.1M
5
FLAM
First Light Asset Management
Minnesota
$144M
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$22.1M -$44.6M -490,671 -67%
Janus Henderson Group
27
Janus Henderson Group
United Kingdom
$20.3M +$19.8M +217,947 +4,057%
Bank of America
28
Bank of America
North Carolina
$20.2M +$1.7M +18,685 +9%
Millennium Management
29
Millennium Management
New York
$19.5M -$49.9M -549,212 -72%
Charles Schwab
30
Charles Schwab
California
$18.8M +$73.2K +805 +0.4%
MB
31
MPM BioImpact
Massachusetts
$16.5M -$1.62M -17,307 -9%
FAM
32
Fred Alger Management
New York
$15.9M -$121M -1,334,703 -88%
SCM
33
Soleus Capital Management
Connecticut
$15.9M +$15.9M +174,592 New
Norges Bank
34
Norges Bank
Norway
$15M -$3.62M -39,837 -19%
Victory Capital Management
35
Victory Capital Management
Texas
$14.7M +$14.7M +161,682 New
Voloridge Investment Management
36
Voloridge Investment Management
Florida
$14.5M -$5.28M -58,031 -27%
Goldman Sachs
37
Goldman Sachs
New York
$13M -$11.9M -130,419 -48%
Two Sigma Investments
38
Two Sigma Investments
New York
$11.3M -$1.9M -20,864 -14%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$11.3M -$23.6M -259,591 -68%
JPMorgan Chase & Co
40
JPMorgan Chase & Co
New York
$11.2M -$4.02M -44,173 -26%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$10.8M +$4.32M +47,460 +67%
Nuveen Asset Management
42
Nuveen Asset Management
Illinois
$10.1M +$364K +4,006 +4%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$9.26M +$7.89M +86,819 +577%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$9.24M -$25.2K -277 -0.3%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$8.49M -$20.8M -228,467 -71%
IC
46
Ikarian Capital
Texas
$7.32M +$7.32M +80,564 New
Jane Street
47
Jane Street
New York
$7.19M +$2.49M +27,418 +53%
IHAM
48
Integral Health Asset Management
New York
$6.46M -$1.27M -14,000 -16%
GTC
49
Ghost Tree Capital
New York
$6.36M -$39.1M -430,000 -86%
AllianceBernstein
50
AllianceBernstein
Tennessee
$6.27M -$4.03M -44,366 -39%
1
2
3 4 5